跳至主要内容
临床试验/CTRI/2025/04/085064
CTRI/2025/04/085064尚未招募不适用

Impact of Kutaj Ghanvati on bleeding in Hemorrhoids(Rakta Arsh).

Central Council for Research in Ayurvedic Sciences1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年4月30日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
30
试验地点
1
主要终点
To assess hemostatic activity of Kutaj Ghanvati in the case of bleeding hemorrhoids.

研究概览

简要总结

My research project has been selected by CCRAS SPARK-03 (session -2024-2025).

For which ethical clearance and literature work is in progress .

My research will start most probably from February 2025.It will take 2 months to complete this research work

Right now I am arranging drugs for my spark research work.

After the study initiation the progress report is to be made and have to sent higher authority.

After the completion of study I will make discussion statistical analysis and conclude with outcomes as achieved.

研究设计

研究类型
Interventional
分配方式
Na
盲法
Participant Blinded

入排标准

年龄范围
20.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • 1- Hemorrhoid degree- Patients diagnosed with 1st degree, 2nd degree, 3rd degree, and 4th degree bleeding hemorrhoids.
  • 2- Hemoglobin Levels- Patients with hemoglobin levels greater than 8 gm/dL.

排除标准

  • Patients will be excluded from the study if they have any of the following conditions:
  • Thrombosed hemorrhoids.
  • Fissure in ano or prolapse of the rectum.
  • Hemorrhoids are associated with ulcerative colitis, tuberculosis (Koch’s disease), diabetes mellitus, or hepatic disorders.
  • Blood dyscrasias.
  • HIV-positive or HbsAg-positive patients.

结局指标

主要结局

To assess hemostatic activity of Kutaj Ghanvati in the case of bleeding hemorrhoids.

时间窗: Pateint will be followed up on 1st, 3rd, 5th, 7th and 14th day.

次要结局

  • The results of treatment will be classified based on the degree of relief experienced by the patients:

研究者

申办方类型
Research institution
责任方
Principal Investigator
主要研究者

Tanya Mann

A&U Tibbia College and Hospital

研究点 (1)

Loading locations...

相似试验